Table S3. Clinical characteristics of 122 CRC patients in indicated groups. (DOCX 16 kb
(a) The mRNA level of IκBα in CRC cell lines. (b) The correlation between miR-196a-5p and IκBα mRNA ...
Table S1. Primers for genotyping of CXCR4 transgenic mice and ApcMin/+ mice. Table S2. Antibodies fo...
Figure S6. Effects of SDCSC-exosomal miR-146a-5p on survival of neutrophils. (A) RT-qPCR examining e...
Table S1. Clinical characteristics of CRC patients in training phase. (DOCX 19 kb
Figure S1. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin ...
Figure S5. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S2. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin ...
Figure S3. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S4. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S7. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Figure S6. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Table S1. The groups of CRC patient population used in different figures. (DOC 29 kb
Figure S1. Isolation and characterization of matched CAFs and counterpart NFs from CRC patients. Fig...
Table S1. Information of miR-200 and 495 polymorphisms for PCR-RFLP. Table S2. Comparison of genotyp...
Table S1. Clinicopathological characteristics of EOC patients. (nâ=â62) (DOC 36 kb
(a) The mRNA level of IκBα in CRC cell lines. (b) The correlation between miR-196a-5p and IκBα mRNA ...
Table S1. Primers for genotyping of CXCR4 transgenic mice and ApcMin/+ mice. Table S2. Antibodies fo...
Figure S6. Effects of SDCSC-exosomal miR-146a-5p on survival of neutrophils. (A) RT-qPCR examining e...
Table S1. Clinical characteristics of CRC patients in training phase. (DOCX 19 kb
Figure S1. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin ...
Figure S5. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S2. related to Fig. 2. miR-128-3p expression in CRC cell lines and its effect on oxaliplatin ...
Figure S3. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S4. related to Fig. 5. Intercellular transfer of miR-128-3p by 128-Exo sensitized CRC cells t...
Figure S7. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Figure S6. related to Fig. 6. Exosomes containing miR-128-3p sensitized CRC cells to oxaliplatin by ...
Table S1. The groups of CRC patient population used in different figures. (DOC 29 kb
Figure S1. Isolation and characterization of matched CAFs and counterpart NFs from CRC patients. Fig...
Table S1. Information of miR-200 and 495 polymorphisms for PCR-RFLP. Table S2. Comparison of genotyp...
Table S1. Clinicopathological characteristics of EOC patients. (nâ=â62) (DOC 36 kb
(a) The mRNA level of IκBα in CRC cell lines. (b) The correlation between miR-196a-5p and IκBα mRNA ...
Table S1. Primers for genotyping of CXCR4 transgenic mice and ApcMin/+ mice. Table S2. Antibodies fo...
Figure S6. Effects of SDCSC-exosomal miR-146a-5p on survival of neutrophils. (A) RT-qPCR examining e...